NeuroPace, Inc. (NPCE) Revenue History
Annual and quarterly revenue from 2019 to present
NPCE Revenue Over Time (2019–2025)
NPCE Revenue Growth History
6 of 6 years with positive growth- FY2019 revenue growth
- N/A
- FY2020 revenue growth
- +11.3%
- FY2021 revenue growth
- +9.8%
- FY2022 revenue growth
- +0.7%
- FY2023 revenue growth
- +43.7%
- FY2024 revenue growth
- +22.1%
- FY2025 revenue growth
- +25.1%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $22.1M | -2.0% |
| Q4 2025 | $26.6M | +23.9% |
| Q3 2025 | $27.4M | +29.9% |
| Q2 2025 | $23.5M | +22.1% |
| Q1 2025 | $22.5M | +24.3% |
| Q4 2024 | $21.5M | +19.2% |
| Q3 2024 | $21.1M | +28.2% |
| Q2 2024 | $19.3M | +16.6% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown
NPCE's revenue distribution by segment and geography
By Geography
NPCE Revenue Analysis (2019–2025)
Current Revenue & Growth
As of June 23, 2026, NeuroPace, Inc. (NPCE) generated trailing twelve-month (TTM) revenue of $99.5 million, reflecting slight decline in growth of -2.0% year-over-year. The most recent quarter (Q1 2026) recorded $22.1 million in revenue, down 17.0% sequentially.
Historical Growth Trajectory
NPCE's 5-year compound annual growth rate (CAGR) stands at +19.4%, indicating consistent double-digit revenue growth. The 3-year CAGR of +30.0% exceeds the 5-year average, indicating an acceleration in the most recent period. NeuroPace, Inc.'s highest annual revenue of $100.0 million was recorded in 2025, an all-time high.
Peer Comparison
Compared to Healthcare sector peers — including LIVN (+12.4% YoY), ELMD (+16.8% YoY), and MDT (+6.9% YoY) — NPCE has underperformed the peer group in revenue growth. Compare NPCE vs LIVN →
NPCE Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| NPCECurrent | $100M | -2.0% | +19.4% | -16.3% | |
 LIVN | $1.4B | +12.4% | +8.2% | 14.4% | |
 ELMD | $64M | +16.8% | +14.5% | 15.4% | |
 MDT | $33.5B | +6.9% | +3.0% | 17.8% | |
 ABT | $42.0B | +6.4% | +5.6% | 16.3% | |
 BSX | $20.1B | +19.9% | +15.2% | 19.8% |
NPCE Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $100.0M | +25.1% | $77.2M | 77.2% | $-16,338,000 | -16.3% |
| 2024 | $79.9M | +22.1% | $59.1M | 73.9% | $-21,671,000 | -27.1% |
| 2023 | $65.4M | +43.7% | $48.1M | 73.6% | $-27,174,000 | -41.5% |
| 2022 | $45.5M | +0.7% | $32.5M | 71.4% | $-40,794,000 | -89.6% |
| 2021 | $45.2M | +9.8% | $33.4M | 74.0% | $-23,737,000 | -52.5% |
| 2020 | $41.1M | +11.3% | $30.3M | 73.6% | $-13,051,000 | -31.7% |
| 2019 | $37.0M | - | $26.5M | 71.6% | $-22,031,000 | -59.6% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
NPCE — Frequently Asked Questions
Quick answers to the most common questions about buying NPCE stock.
Is NPCE's revenue growth accelerating or slowing?
NPCE revenue growth is slowing. TTM revenue is $100M, up -2.0% year-over-year — below the 5-year CAGR of +19.4%. The deceleration suggests maturing end-markets or increased competition.
What is NPCE's revenue history from 2019 to 2026?
NeuroPace, Inc. (NPCE) revenue history spans 2019 to 2026. TTM revenue as of 2026 is $100M, growing at -2.0% YoY. The 5-year CAGR is +19.4%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is NPCE's long-term revenue growth rate (CAGR)?
NeuroPace, Inc.'s 5-year revenue CAGR of +19.4% reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of -2.0% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for NPCE.
Why does NPCE's quarterly revenue fluctuate?
NPCE quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. NeuroPace, Inc.'s revenue data from 2019 to 2026 shows full historical quarterly detail on this page.
How is NPCE's revenue distributed by segment?
NPCE reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does NPCE's revenue compare to industry peers?
NeuroPace, Inc. (NPCE) with TTM revenue of $100M and -2.0% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.